Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:07 PM UTC
| NCT Number | NCT05344833 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 2 sites in the US |
| Sponsor | University of Illinois at Chicago |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of July 16, 2026: Clinical trial NCT05344833 is currently recruiting participants. This phase2 study for multiple myeloma is actively seeking new participants at 2 locations across the United States. The study is sponsored by University of Illinois at Chicago. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05344833 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05344833 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.